Zuo-Neng Wang

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
To develop novel analgesics with no side effects or less side effects than traditional opioids is highly demanded to treat opioid receptor mediated pain and addiction issues. Recently, κ-opioid receptor (KOR) has been established as an attractive target, although its selective agonists could bear heterogeneous pharmacological activities. In this study, we(More)
  • 1